GenSight Biologics S.A. (EPA:SIGHT)
0.0757
+0.0013 (1.75%)
Nov 12, 2026, 9:20 AM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €17.75 million as of November 11, 2026. It is the 37,003rd most valuable company in the world and the 462nd biggest in France. Its market cap has decreased by 26.33% in one year.
Market Cap
17.75M
Enterprise Value
28.92M
Revenue
-251.00K
Global Rank
Country Rank
#462 France
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 17.75M, a decrease of -92.96%. That is a compound annual growth rate of -22.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 17.75M | -22.88% |
| Dec 31, 2025 | 23.02M | -30.35% |
| Dec 31, 2024 | 33.05M | 28.79% |
| Dec 29, 2023 | 25.66M | -83.46% |
| Dec 30, 2022 | 155.20M | -39.23% |
| Dec 31, 2021 | 255.38M | -16.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| THX Pharma Société Anonyme | 50.90M |
| OSE Immunotherapeutics | 40.83M |
| Fermentalg | 38.04M |
| Nicox | 28.78M |
| MaaT Pharma | 20.16M |
| genOway Société anonyme | 17.61M |
| Biophytis | 14.39M |
| Aelis Farma | 11.90M |